López M, Escobar A, Alfaro J, Fodor M, Larrondo M, Ferrada C, Salazar-Onfray F.
[Advances in cellular immunotherapy for malignant melanoma]

López M, Aguilera R, Pérez C, Mendoza-Naranjo A, Pereda C, Ramirez M, Ferrada C, Aguillón JC, Salazar-Onfray F.
The role of regulatory T lymphocytes in the induced immune response mediated by biological vaccines.

López MN, Pereda C, Ramírez M, Mendoza-Naranjo A, Serrano A, Ferreira A, Poblete R, Kalergis AM, Kiessling R, Salazar-Onfray F.
Melanocortin 1 receptor is expressed by uveal malignant melanoma and can be considered a new target for diagnosis and immunotherapy.

Salazar-Onfray F, López MN, Mendoza-Naranjo A.
Paradoxical effects of cytokines in tumor immune surveillance and tumor immune escape.

Mendoza-Naranjo A, Saéz PJ, Johansson CC, Ramírez M, Mandakovic D, Pereda C, López MN, Kiessling R, Sáez JC, Salazar-Onfray F.
Functional gap junctions facilitate melanoma antigen transfer and cross-presentation between human dendritic cells.

Aguillón JC, Contreras J, Dotte A, Cruzat A, Catalán D, Salazar L, Molina MC, Guerrero J, López M, Soto L, Salazar-Onfray F, Cuchacovich M.
New immunological weapons for medicine in the 21st Century: biological therapy based on the use of the latest generation monoclonal antibodies]